Clinical Trial Update: A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Longbio Pharma has completed a Phase 1 trial evaluating single and multiple doses of LP-005 in healthy adult participants to explore its safety and pharmacology…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• LP-005

Snippet

Sponsor: Longbio Pharma | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | Status: COMPLETED